Cardlytics (NASDAQ:CDLX) CEO Amit Gupta Sells 9,640 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 9,640 shares of the business’s stock in a transaction on Monday, July 6th. The stock was sold at an average price of $4.39, for a total transaction of $42,319.60. Following the completion of the sale, the chief executive officer owned 113,850 shares in the company, valued at approximately $499,801.50. The trade was a 7.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Amit Gupta also recently made the following trade(s):

• On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total transaction of $28,526.22.

Cardlytics Stock Up 1.3%

Shares of Cardlytics stock opened at $4.42 on Tuesday. Cardlytics, Inc. has a twelve month low of $4.25 and a twelve month high of $32.80. The business has a 50-day moving average price of $6.26 and a 200-day moving average price of $8.70. The firm has a market cap of $25.71 million, a price-to-earnings ratio of -0.25 and a beta of 0.61.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Goldman Sachs Group Inc. grew its stake in shares of Cardlytics by 15.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after buying an additional 14,273 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Cardlytics by 3.3% during the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after acquiring an additional 20,908 shares during the period. Qube Research & Technologies Ltd purchased a new position in Cardlytics during the 3rd quarter valued at $55,000. Boothbay Fund Management LLC bought a new position in Cardlytics in the 3rd quarter valued at $74,000. Finally, Virtu Financial LLC bought a new position in Cardlytics in the 4th quarter valued at $39,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Lake Street Capital set a $10.00 price objective on Cardlytics in a research note on Friday, May 8th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a report on Friday, April 10th. Finally, Wall Street Zen cut shares of Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, June 13th. Two analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Cardlytics currently has a consensus rating of “Reduce” and an average price target of $10.00.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.